Annals of Oncology

News:

Once more in St. Gallen
Ann Oncol 9: 463-464.
[PDF] [Request Permissions]

Cancer the main cause of death in Britain
Ann Oncol 9: 464.
[PDF] [Request Permissions]

Battle over budget: A threat for cancer research?
Ann Oncol 9: 464-465.
[PDF] [Request Permissions]

US cancer rates fall for the first time
Ann Oncol 9: 465.
[PDF] [Request Permissions]

Awards, appointments
Ann Oncol 9: 465-466.
[PDF] [Request Permissions]

Perhaps not everyone knows that...
Ann Oncol 9: 466-468.
[PDF] [Request Permissions]

Book reviews:

J. Armitage

Book review
Ann Oncol 9: 468.
[PDF] [Request Permissions]

H. Neuenschwander

Book review
Ann Oncol 9: 474.
[PDF] [Request Permissions]

M. Fey

Book review
Ann Oncol 9: 568.
[PDF] [Request Permissions]

Editorial:

C. Trépo, P. Berthillon, and L. Vitvitski

HCV and lymphoproliferative diseases
Ann Oncol 9: 469-470.
[PDF] [Request Permissions]

E. E. Vokes and T. F. Pajak

Enhancing the therapeutic index of concomitant chemoradiotherapy for head and neck cancer
Ann Oncol 9: 471-473.
[PDF] [Request Permissions]

Review:

C. C. Earle, D. Coyle, and W. K. Evans

Cost-effectiveness analysis in oncology
Ann Oncol 9: 475-482.
[Abstract] [PDF] [Request Permissions]

Review on evidence-based cancer medicine:

D. Moher and K. F. Schulz

Randomized controlled trials in cancer: Improving the quality of their reports will also facilitate better conduct
Ann Oncol 9: 483-487.
[PDF] [Request Permissions]

Commentary:

A. Goldhirsch, M. Colleoni, A. S. Coates, M. Castiglione-Gertsch, R. D. Gelber, and for the International Breast Cancer Study Group (IBCSG)

Adding adjuvant CMF chemotherapy to either radiotherapy or tamoxifen: Are all CMFs alike?
Ann Oncol 9: 489-493.
[Abstract] [PDF] [Request Permissions]

Original articles:

M. Luppi, G. Longo, M. G. Ferrari, P. Barozzi, R. Marasca, M. Morselli, C. Valenti, T. Mascia, L. Vandelli, D. Vallisa, L. Cavanna, and G. Torelli

Clinico-pathological characterization of hepatitis C virus-related B-cell non-Hodgkin's lymphomas without symptomatic cryoglobulinemia
Ann Oncol 9: 495-498.
[Abstract] [PDF] [Request Permissions]

F. Silvestri, G. Barillari, R. Fanin, F. Salmaso, C. Pipan, E. Falasca, F. Puglisi, L. Mariuzzi, F. Zaja, L. Infanti, F. Patriarca, A. Candoni, A. Rogato, C. Di Loreto, G.A. Botta, and M. Baccarani

Impact of hepatitis C virus infection on clinical features, quality of life and survival of patients with lymphoplasmacytoid lymphoma/immunocytoma
Ann Oncol 9: 499-504.
[Abstract] [PDF] [Request Permissions]

I Büntzel, K. K{diaeresis}ttner, D. Fröhlich, and M. Glatzel

Selective cytoprotection with amifostine in concurrent radiochemotherapy for head and neck cancer
Ann Oncol 9: 505-509.
[Abstract] [PDF] [Request Permissions]

F. Cabanillas, J. Rodriguez-Diaz Pavón, F. B. Hagemeister, P. McLaughlin, M. A. Rodriguez, J. E. Romaguera, K. Dong, and T. Moon

Alternating triple therapy for the treatment of intermediate grade and immunoblastic lymphoma
Ann Oncol 9: 511-518.
[Abstract] [PDF] [Request Permissions]

R. Siebert, P. Matthiesen, S. Harder, Y. Zhang, A. Borowski, R. Zühlke-Jenisch, H. Plendl, S. Metzke, S. Joos, E. Zucca, K. Weber-Matthiesen, E. Roggero, W. Grote, and B. Schlegelberger

Application of interphase cytogenetics for the detection of t(11;14)(ql3;q32) in mantle cell lymphomas
Ann Oncol 9: 519-526.
[Abstract] [PDF] [Request Permissions]

K. Tobinai, Y. Kobayashi, M. Narabayashi, M. Ogura, Y. Kagami, Y. Morishima, T. Ohtsu, T. Igarashi, Y. Sasaki, T. Kinoshita, T. Murate, and Members of the IDEC-C2B8 Study Group

Feasibility and pharmacokinetic study of a chimeric anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab) in relapsed B-cell lymphoma
Ann Oncol 9: 527-534.
[Abstract] [PDF] [Request Permissions]

M. M. Borner, M. Castiglione, M. Bacchi, W. Weber, R. Herrmann, M. F. Fey, O. Pagani, S. Leyvraz, R. Morant, B. Pestalozzi, S. Hanselmann, A. Goldhirsch, and for the Swiss Group for Clinical Cancer Research (SAKK)

The impact of adding low-dose leucovorin to monthly 5-fluorouracil in advanced colorectal carcinoma: Results of a phase III trial
Ann Oncol 9: 535-541.
[Abstract] [PDF] [Request Permissions]

M. L. G. Janssen-Heijnen, R. M. Schipper, P. J. J. M. Klinkhamer, M. A. Crommelin, and J.-W.W. Coebergh

Improvement and plateau in survival of small-cell lung cancer since 1975: A population-based study
Ann Oncol 9: 543-547.
[Abstract] [PDF] [Request Permissions]

G. Apolone, A. Filiberti, S. Cifani, R. Ruggiata, and P. Mosconi

Evaluation of the EORTC QLQ-C30 questionnaire: A comparison with SF-36 Health Survey in a cohort of Italian long-survival cancer patients
Ann Oncol 9: 549-557.
[Abstract] [PDF] [Request Permissions]

Clinical case:

M. Pruckmayer, C. Glaser, C. Marosi, and T. Leitha

Mandibular pain as the leading clinical symptom for metastatic disease: Nine cases and review of the literature
Ann Oncol 9: 559-564.
[Abstract] [PDF] [Request Permissions]

Short report:

C. Campisi, A. Fabi, P. Papaldo, S. Tomao, B. Massidda, A. Zappala, M. T. Ionta, and F. Cognetti

Ifosfamide given by continuous-intravenous infusion in association with vinorelbine in patients with anthracycline-resistant metastatic breast cancer: A phase I–II clinical trial
Ann Oncol 9: 565-567.
[Abstract] [PDF] [Request Permissions]

K. Mross, B. Hauns, B. H{ring}ring, T. Bauknecht, H. G. Meerpohl, C. Unger, and H. Maier-Lenz

Clinical phase I study with one-hour paclitaxel infusion
Ann Oncol 9: 569-572.
[Abstract] [PDF] [Request Permissions]

Letters to the editor:

J. Lokich and N. Anderson

Paclitaxel hypersensitivity reactions: A role for docetaxel substitution
Ann Oncol 9: 573.
[PDF] [Request Permissions]

I. Genvresse, K. Akrivakis, B. Flath, E. Späth-Schwalbe, and K. Possinger

Pneumocystis carinii pneumonia in breast cancer
Ann Oncol 9: 573-574.
[PDF] [Request Permissions]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.